Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations - Concepedia

Concepedia

Publication | Open Access

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations

DOI Full Paper Access

81

Citations

12

References

2015

Year

James F. Donohue, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church

Respiratory Medicine

Abstract

DB2114930/NCT01817764; DB2114951/NCT01879410.

References

	Year	Citations

Page 1